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Purpose: Our aims were to: 1) describe participation in people with Parkinson disease (PD), 2) evaluate 
the relationship between quality of life and participation, and 3) determine which mobility measures 
predict participation. 
Methods: Participants with idiopathic PD (n=62) were tested off medication for participation (Activity 
Card Sort), quality of life (PDQ-39), disease severity (MDS-UPDRS), and mobility (Berg Balance Scale, Five 
Time Sit to Stand (FTSTS) , Six Minute Walk, forward walking velocity, dual-task walking velocity, and 
Freezing of Gait Questionnaire (FOGQ)).  Relationships of all variables to participation were examined 
using Pearson correlations.  Subsequent regression analysis was employed to determine which mobility 
measures best predicted participation. 
Results: Participants with PD retained, on average, 78.3% (SD = 15.6%) of total activities. Participation 
was negatively correlated with all PDQ-39 domains (r range -.36 to .-78, all p < 0.005) with the mobility 
domain having the strongest correlation. All mobility measures were significantly correlated with 
participation, with the final regression model including only FTSTS and FOGQ which combined explained 
37% of the variance in participation.  
Conclusions: Participation is highly related to mobility-related QOL and may be most impacted by ability 





Parkinson Disease (PD) is a progressive, neurologic disorder associated with degeneration of the 
dopamine-producing cells in the substantia nigra [1]. The cardinal features of PD are rigidity, 
bradykinesia, tremor, and postural instability [2]. In an individual with PD, it is understood that these 
motor symptoms can disrupt daily functions, roles and activities [3]. These functions, roles and activities 
comprise the meaning of the term participation, which is defined by the International Classification of 
Functioning, Disability and Health (ICF) as the patient’s involvement in life situations [4]. Engagement in 
social activities has been positively correlated with well-being [5]; participation in activities has been 
shown to contribute to the maintenance of function and quality of life in older adults [6]. Because of the 
association between activity engagement, quality of life, and well-being, it is essential to understand 
how participation in activities may or may not be affected in individuals with PD. 
 To our knowledge, participation in activities has not yet been described or quantified in 
individuals with PD, though several studies have examined level of physical activity. Previous studies 
have used activity monitors to determine amount of walking activity performed by individuals with PD 
[7-9]. Others have used qualitative methods to determine how PD has affected physical mobility and 
quality of life [10, 11]. However, it is unclear whether understanding aspects of an individual’s physical 
activity may be associated with one’s participation in life situations. Although participation in activities 
has not been described or quantified in PD, previous studies described, and occasionally quantified, 
participation in people with neurologic conditions in other populations [12- 14]. The Activity Card Sort 
(ACS) [15] has emerged as a unique tool for measuring participation in activities in older adults and 
individuals with a neurological condition [13, 16-22]. The ACS contains items from all domains of the ICF 
‘Activity & Participation’ category [4]. 
The purposes of this study are to: 1) describe and quantify participation in activities and social 
participation in individuals with PD using the Activity Card Sort and 2) evaluate the relationship between 
participation in activities and quality of life in those with PD, and 3) determine which factors are most 
related to participation in activities. We hypothesized that activity engagement and social participation 
would be reduced in those with PD and would be negatively correlated with disease severity. 
Identification of factors that contribute to reduced participation in activities is important in order to 
facilitate the development of interventions to increase activity and social participation and thereby, 
potentially improve quality of life for people with PD. 
Methods 
Participants 
Participants for this study were recruited using databases from the Washington University 
School of Medicine Movement Disorders Centre and from the Washington University Volunteers for 
Health, advertisements in the Greater St. Louis Chapter American Parkinson Disease Association 
newsletter, and word of mouth. The target population for this study was individuals of any age with a 
diagnosis of idiopathic PD (Hoehn & Yahr (H&Y) Stages 1-4).  Via telephone interview, potential 
participants were excluded if found to have any of the following: 1) a serious medical problem, 2) 
evidence of abnormality other than PD-related changes on brain imaging (previously done for clinical 
evaluations-not part of this research), 3) history or evidence of neurological deficit other than PD that 
could interfere, such as previous stroke or muscle disease, 4) history or evidence of orthopedic or 
muscular problem, or 5) a diagnosis or evidence of dementia. Recruitment was done as part of a larger 
clinical trial and data were collected as part of the baseline evaluation for this larger trial.  The 
recruitment goal for the larger study was 60 subjects.   Each participant gave informed consent in 
accordance with the policies and procedures of the Washington University School of Medicine’s Human 
Research Protection Office.  
Outcome Measures 
The ACS is a collection of 89 pictured activity cards that are sorted by an individual in order to 
determine how one’s participation in activities has been affected due to the onset of a certain condition. 
The pictured activities fall into one of four domains which are: 1) Instrumental Activity of Daily Living 
(IADL), 2) Low-Demand Leisure Activity (LDLA), 3) High-Demand Leisure Activity (HDLA), and 4) Social 
Activity. Participants then sort these cards into one of five categories: 1) Continued to Do Since Illness, 
2) Do Less Since Illness, 3) Given up Due to Illness, 4) New Activity Since Illness, or 5) Not Done Prior to 
Illness, with PD being the illness to which the categories referred. Following completion, the examiner 
would use the ACS scoring sheet to determine the percentage of activities retained in IADL, LDLA, HDLA, 
and Social, as well as the total percentage of activities retained. Baum and Edwards previously 
established test-retest reliability of the ACS in a study of twenty community-residing older adults. The 
test-retest reliability coefficient was .89 with one week between testing [15]. Katz and colleagues 
studied the discriminative validity of the ACS using 5 groups (healthy adults, healthy older adults, people 
who have had a stroke, people with multiple sclerosis, and spouses and caregivers of people with 
Alzheimer’s disease) and found significant differences between groups (p < .0001) for current activities 
performed and retained activity levels [13]. 
A variety of measures were used in the study to examine characteristics of disease severity and 
mobility in participants with PD. The full Movement Disorders Society Unified Parkinson Disease Rating 
Scale (MDS-UPDRS) was completed [23]. The Berg Balance Scale (BBS) is a well-established tool 
commonly used to measure balance and has been found to be both reliable and valid [24-26]. Interrater 
and intrarater reliability were measured when testing individuals with PD, the intraclass correlation 
coefficients were 0.74 and 0.87, respectively [24]. The Five Times Sit to Stand test (FTSTS) has been 
shown to possess discriminative validity in that it was able to discriminate between individuals with and 
individuals without balance disorders [27]. Lord and colleagues found that strength explains a significant 
portion of the variance in performance of FTSTS [28] Test-retest reliability was found to be high (ICC = 
.89) for a subset of thirty older adults with a variety of health conditions; however, those with PD were 
excluded [28]. Forward walking and dual task walking velocities were recorded using the 5-metre, 
computerized GAITRite walkway (CIR Systems, Inc, Havertown, PA). The Six Minute Walk Test (6MWT) is 
a commonly used measure of walking capacity in individuals with PD [29-32].  The 6MWT has 
demonstrated high test-retest reliability (ICC = .96 [33] and ICC = .95 [34]) when examining those with 
PD. 
Two questionnaires were used to assess each participant’s quality of life and freezing of gait. 
Quality of life was measured using the Parkinson Disease Questionnaire-39 (PDQ-39), which has 
demonstrated good internal and test-retest reliability, as well as good construct validity [35-36] For the 
summary index score, high internal reliability was found with a Cronbach’s α of 0.84 [37]. The Freezing 
of Gait Questionnaire [38] was issued to quantify freezing of gait. Giladi and colleagues found the FOGQ 
to be a reliable (r = 0.84) and valid tool as it was able to identify 85.9% of those who experience freezing 
[39]. 
Procedures 
All of the aforementioned outcome measures were completed in the Locomotor Control 
Laboratory in the Program in Physical Therapy at Washington University School of Medicine. In order to 
avoid variability in response to anti-Parkinson medication, participants were tested OFF medication. For 
a participant to be considered OFF of medication, the participant must have reported a withdrawal of all 
anti-Parkinson medication for greater than or equal to 12 hours. All participants were assessed by the 
same rater. The participants completed each outcome measure in the following order: 1) MDS-UPDRS 
III, 2) BBS, 3) Forward walking velocity (FWV) and dual task walking velocity (DTWV) on the GAITRite, 4) 
FTSTS, 5) 6MWT. Regarding forward walking, participants completed three trials at a self-determined 
‘normal’ speed. Dual task walking involved three trials in which the participant walked forward at their 
‘normal’ speed while naming as many words as possible that began with a certain letter of the alphabet. 
The first letter used was ‘H’, the second, ‘L’, and the third was ‘T’. The three trials for both FWV and 
DTWV were averaged to determine the mean walking velocity for each condition. Following the 
completion of all mobility measures, the participants were instructed to take their usual dose of anti-
Parkinson medication. The participants then completed the ACS, PDQ-39, and FOGQ, and MDS-UPDRS-I, 
II, IV (non-motor, activities of daily living, and motor complication subscales) [24]. 
Statistics 
 To determine the relationships between participation in activities, as assessed by the 
percentage of total retained activities on the ACS (ACStotal), and other measures, Pearson correlations 
were used.  No corrections were made to account for the multiple relationships examined, as we 
considered this to be an exploratory analysis given that this is the first study to examine the ACS in 
individuals with PD.  Those measures most related to ACStotal then were entered into a simultaneous 
regression analysis to determine which factors are most predictive of participation levels. All analyses 
were conducted with NCSS software [40]. 
Results 
 Of the 112 individuals meeting all eligibility criteria who were invited to participate, 62 agreed to 
take part in the study.  Those who agreed to participate were not systematically different from those 
who opted not to participate.  Evaluations of participants began October 1st, 2009 and ended on 
December 31st, 2009. The final sample was 56% male with a mean age ± SD of 70.3 ± 8.9 years and an 
average H&Y stage ± SD of 2.5 ± 0.5 (range 1-4). Figure 1 displays the percentage of retained activities 
for each category of the ACS, including ACStotal.  Regarding demographic and disease severity 
information, age was mildly but significantly correlated with participation (i.e.  ACStotal), while gender 
and H&Y stage were not related to participation in activities (see Table 1). All sections of the PDQ-39 
demonstrated significant correlations with ACStotal ranging from mild to strong with PDQ-Mobility having 
the strongest relationship with participation in activities (Table 1).  
All mobility measures were significantly correlated with participation.  Figure 2 shows scatter 
plots illustrating the relationships between each mobility measure and ACStotal.  Many of the mobility 
measures were also highly correlated with one another (Table 2).  As such, it was not appropriate to 
include all mobility measures in the regression analyses due to concerns about colinearity.  The final 
regression model included only two mobility measures, FTSTS and FOGQ, which combined explained 
37% of the variance in ACStotal (Table 3). It is worth noting that the BBS alone was able to explain 24% of 
the variance in ACStotal but was not included in the final regression because of its high correlations with 
the other mobility measures.  Addition of the BBS, 6MWT, FWV, or DWV alone and in various 
combinations resulted in mild to severe colinearity and provided only minimal increases in the amount 
of variance explained. 
Discussion 
 Restoration of physical function is often the focus of rehabilitation programmes, while 
participation in activities is often left unaddressed. It is not yet understood whether or not participation 
is reduced in those with PD, and as such, this study sought to characterize activity participation levels in 
those with PD using the ACS and to determine the factors to which activity engagement is related. 
Individuals with PD demonstrated reductions in all categories of the ACS. Total percent of activities 
retained was significantly negatively correlated with disease severity as assessed by the MDS-UPDRS.  
There was also a strong, negative correlation between overall QOL, as measured by the PDQ-39, 
and participation in activities. The mobility section of the PDQ-39 demonstrated an even stronger 
inverse relationship with the ACS. It has been previously established that mobility plays a significant role 
in QOL [41-44]; however, until now mobility-related QOL has not yet been examined in relation to 
participation in activities. This study shows that those with decreased QOL participate less in a wide 
range of activities with a strong specific relationship for mobility. While mobility is a term that 
encompasses many things, it is important to understand which aspects of mobility may affect activity 
engagement in individuals with PD. 
Overall, FTSTS and FOGQ combined to account for 37% of the variance in participation in 
activities. While the other mobility measures were also significantly correlated with participation, they 
were also highly correlated with one another.  FTSTS and FOGQ appear to be measuring two distinct and 
unrelated aspects of mobility, both of which may influence participation.  The identification of mobility 
factors that influence activity engagement is important for rehabilitation professionals who must decide 
which of these modifiable factors to target during interventions. Our results suggest that interventions 
targeted at improving mobility, and in particular lower extremity strength (FTSTS) and freezing of gait, 
may lead to increased participation in high demand leisure activities in individuals with PD; however, 
future research is needed to confirm this hypothesis. 
Comparison to Other Populations 
When compared to the populations (multiple sclerosis, stroke, healthy elderly) studied by Katz 
and colleagues, the participants with PD in this study had a higher percentage of activities retained in all 
ACS categories, except IADL, exceeded only by healthy elderly [13]. It is important to note that an Israeli 
version of the ACS was used in the study by Katz, whereas, in the current study, a US edition of the ACS 
was implemented [13].  
Limitations and Future Directions 
One possible explanation for the high percentage of activities retained in those with PD is that 
the participants had to be willing to travel into the community to take part in this study. As such, our 
sample may reflect those with PD who have retained higher levels of participation than the general PD 
population. The percentage of activities retained would likely be lower if those individuals with PD who 
were homebound were included. Future work could consider administering the ACS in the homes of 
individuals with PD to obtain a clearer picture of participation levels across the full spectrum of the 
disease.  
Cognitive deficits, including dementia, are commonly seen in those stricken with PD [45]; 
however individuals with cognitive impairments or dementia were not included in this study. The 
authors identify the lack of a specific measure for cognitive function as a limitation to the present study. 
It is not yet understood how cognitive function may impact performance on the ACS in those with PD, 
and this would be an important concept requiring further research. 
We also did not employ any correction for the multiple correlational relationships examined, 
given the exploratory nature of the study.  However, we think such a correction would have had little 
impact on the results, as many of the correlations were highly significant (p < 0.0001). 
Conclusion 
 Individuals with PD experience reduced participation in activities. Mobility measures explained a 
substantial portion of the variance in activity engagement, which suggests that mobility significantly 
influences one’s level of participation in activities.  While physical therapists often focus on movement 
activities such as sit to stand, forward walking, turning or other tasks in those with PD, often left 
unaddressed is whether or not improvements in these tasks increase participation in activities. The ACS 
provides insight into the specific roles and activities one performs less or has given up due to the 
disease, and can facilitate an improved client-centered approach to rehabilitation.  Future research is 
necessary to determine whether or not interventions targeted at improving mobility actually increase 
levels of participation in activities in those with PD. 
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Table 1. Pearson Correlations with ACS_Total. 

































PDQ-Bodily Discomfort -0.33 0.008
PDQ-Summary Index -0.66 0.000
 







  BBS FTSTS 6MWT FOG-Q DTWV FWV 
BBS - -0.16 0.79 -0.68 0.63 0.76 
FTSTS 
 
- -0.30 -0.03 -0.27 -0.30 
6MWT 
  
- -0.44 0.80 0.86 
FOGQ 
   
- -0.35 -0.38 
DTWV 
    
- 0.85 
FWV           - 








FTSTS -0.0055 -0.4061 -0.005 0.16 0.21 
FOG-Q -0.0148 -0.4679 -0.011 0.21 0.26 
Figure Legends 
Figure 1. Percentage of activities retained in each of the four categories of the Activity Card Sort as well 
as overall percent retained (ACS_TOTAL).  The four categories are instrumental activities of daily living 
(IADL), low demand leisure activities (LDLA), high demand leisure activities (HDLA), and social activities 
(SOC).  Values are means ± SDs. 
Figure 2. Scatter plots illustrating the relationships between each mobility measure and participation as 
assessed by the ACS.  All mobility measures were significantly correlated with ACS_Total.   
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